$108 Million is the total value of Cypress Point Wealth Management, LLC's 29 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 200.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BTX | Buy | BROOKLYN IMMUNOTHERAPEUTICS | $7,871,000 | -10.3% | 1,887,509 | +100.0% | 7.30% | +133.0% |
New | ROBINHOOD MKTS INC | $2,365,000 | – | 133,143 | +100.0% | 2.19% | – | |
New | BLEND LABS INCcl a | $1,025,000 | – | 139,697 | +100.0% | 0.95% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-01-27
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
PALANTIR TECHNOLOGIES INC | 12 | Q3 2023 | 60.2% |
TESLA INC | 12 | Q3 2023 | 7.3% |
SCHWAB STRATEGIC TR | 12 | Q3 2023 | 6.6% |
VANGUARD WHITEHALL FDS | 12 | Q3 2023 | 5.0% |
OPEN LENDING CORP | 12 | Q3 2023 | 5.6% |
VANGUARD INDEX FDS | 12 | Q3 2023 | 2.3% |
META PLATFORMS INC | 12 | Q3 2023 | 2.0% |
COCA COLA CO | 12 | Q3 2023 | 1.6% |
UNITY SOFTWARE INC | 11 | Q3 2023 | 9.1% |
AFFIRM HLDGS INC | 11 | Q3 2023 | 10.5% |
View Cypress Point Wealth Management, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-07 |
13F-HR | 2024-01-17 |
13F-HR | 2023-10-31 |
13F-HR | 2023-07-20 |
13F-HR | 2023-05-08 |
13F-HR | 2023-02-01 |
13F-HR | 2022-11-01 |
13F-HR | 2022-08-08 |
13F-HR | 2022-04-29 |
13F-HR | 2022-01-27 |
View Cypress Point Wealth Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.